HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Psychedelic Drugs as Therapeutics: No Illusions About the Challenges.

Abstract
Interest in the potential therapeutic benefits of psychedelic agents has recently increased. In addition to psilocybin, a wide variety of agents with psychedelic properties have been proposed and partially tested. However, the challenges of obtaining approval to market a restricted psychotomimetic agent are formidable.
AuthorsEdward M Sellers, Deborah B Leiderman
JournalClinical pharmacology and therapeutics (Clin Pharmacol Ther) Vol. 103 Issue 4 Pg. 561-564 (04 2018) ISSN: 1532-6535 [Electronic] United States
PMID28836272 (Publication Type: Journal Article)
Copyright© 2017 American Society for Clinical Pharmacology and Therapeutics.
Chemical References
  • Hallucinogens
Topics
  • Drug Approval (methods)
  • Drug Discovery (ethics, methods)
  • Hallucinogens (pharmacology, therapeutic use)
  • Humans
  • Mental Disorders (drug therapy)
  • Patient Selection
  • Risk Evaluation and Mitigation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: